Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,330
Total Claims
$760K
Drug Cost
838
Beneficiaries
$906
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-92%
Opioid rate vs peers
0.3% vs 3.8% avg
-23%
Cost per patient vs peers
$906 vs $1,174 avg
+51%
Brand preference vs peers
13.3% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.3%
Opioid Rate
23
Opioid Claims
$334
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 964 claims · $580K
Generic: 6,260 claims · $175K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 74 | $75K |
| Fluticasone/Umeclidin/Vilanter | 86 | $75K |
| Apixaban | 54 | $53K |
| Empagliflozin | 35 | $45K |
| Dulaglutide | 24 | $28K |
| Dapagliflozin Propanediol | 13 | $22K |
| Rivaroxaban | 18 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $21K |
| Sitagliptin Phosphate | 24 | $20K |
| Rosuvastatin Calcium | 207 | $17K |
| Insulin Lispro | 12 | $16K |
| Fluticasone/Vilanterol | 35 | $15K |
| Tirzepatide | 14 | $14K |
| Linaclotide | 17 | $13K |
| Umeclidinium Brm/Vilanterol Tr | 21 | $10K |
Prescribing Profile
Patient Profile
71
Avg Age
70%
Female
1.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About